icatibant (Firazyr, FEAR-ah-zear) for ACE inhibitor-associated angioedema

April 2015

You'll see more interest in using icatibant (Firazyr, FEAR-ah-zear) for ACE inhibitor-associated angioedema.

This subcutaneous bradykinin receptor antagonist is only FDA approved for hereditary angioedema.

But new evidence suggests it's also effective for angioedema due to ACEIs. In fact, patients with ACEI-associated angioedema who receive icatibant 30 mg seem to have complete symptom resolution 19 hours sooner...when compared to usual care.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote